1. The rs3850641 polymorphism of the TNFSF4 gene increases the risk of myocardial infarction in a Chinese Han population
   Changqing Lu et al, 2018, Bioscience Reports CrossRef
2. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO
   Yan Li et al, 2018, Acta Radiologica CrossRef
3. ATF3 Inhibits Tenascin-C-induced Foam Cell Formation in LPS-Stimulated THP-1 Macrophages by Suppressing TLR-4
   Hong Luo et al, 2015, Journal of Atherosclerosis and Thrombosis CrossRef
4. Evaluation of the serum levels of Mannose binding lectin‐2, tenascin‐C, and total antioxidant capacity in patients with coronary artery disease
   Hamed Mehri et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
5. MR targeted imaging for the expression of tenascin‐C in myocardial infarction in vivo
   Jiacheng Song et al, 2017, Journal of Magnetic Resonance Imaging CrossRef
6. Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome
   Murugaiyan Vasanthi et al, 2020, Journal of Medical Biochemistry CrossRef
7. Value of serum tenascin-C in patients with acute myocardial infarction
   Rania Gaber et al, 2016, Alexandria Journal of Medicine CrossRef
8. Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
   Julius L. Decano et al, 2018, Frontiers in Cardiovascular Medicine CrossRef
9. OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells
   Qing-Qing Wu et al, 2016, Clinical Science CrossRef